Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001209191-16-108183

Options or other derivatives

  • VP Global Regulatory & Quality acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mitchell David Chilton VP Global Regulatory & Quality 2016-03-10 Grant or award · Stock Option (Right to Buy) +25,000 25,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…